Phocas Financial Corp’s Cardinal Health CAH Stock Holding History

Phocas Financial Corp’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-940	Closed	-$44K	–	207
2019 Q2	$44K	Buy	+940	New	+$43.4K	﹤0.01%	265

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Phocas Financial Corp's CAH Position: Q3 2019 in Review

Phocas Financial Corp sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 940 shares — an estimated $44K sold.

Phocas Financial Corp first reported a position in CAH in Q2 2019 and held it in 1 quarter. The position peaked at $44K in Q2 2019. 663 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

Phocas Financial Corp reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
Phocas Financial Corp sold 940 Cardinal Health shares in Q3 2019, an estimated $44K.
Phocas Financial Corp first reported a position in Cardinal Health in Q2 2019 and held it in 1 quarter.
Phocas Financial Corp's Cardinal Health position peaked at $44K in Q2 2019.
663 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Phocas Financial Corp's 13F filing for Q3 2019, filed 15 Nov 2019.